Literature DB >> 1985736

A comparison of Ho's, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma.

P M Teo1, S F Leung, P Yu, S Y Tsao, W Foo, W Shiu.   

Abstract

Five hundred sixty-four nasopharyngeal carcinomas (NPC), mostly of undifferentiated histologic type, were studied for survival, distant metastasis, and local recurrence. All had computerized tomography of the nasopharynx and skull base (CT-NP) and fiberoptic nasopharyngoscopy for evaluation of the primary tumor. Regional disease was assessed by palpation. A computer data base was formed on presentation, containing all information required for staging according to Ho's, the International Union Against Cancer (UICC), and the American Joint Committee (AJC) classifications. The three were compared for their efficacy in predicting prognosis. Ho's classification was superior to the other two because its overall stages differed from one another more significantly in the actuarial survival (ASR), disease-free survival (DFS), and freedom from distant metastasis (FDM) rates, and its N staging was more accurate in predicting FDM. Stages T1 and T2 of UICC/AJC were similar in the freedom from local recurrence rate (FLR) and should be grouped together, equivalent to Ho's T1. A more even patients number distribution among the stages also favored the use of Ho's classification.

Entities:  

Mesh:

Year:  1991        PMID: 1985736     DOI: 10.1002/1097-0142(19910115)67:2<434::aid-cncr2820670219>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma.

Authors:  Gengming Wang; Hao Jiang; Hongbo Xu; Qian Sun; Yan Zhou; Ping Xiang; Zenong Cheng; Yajun Zhang; Yufu Zhou; Qing Guo; Xinglong DU; Shuxiu Xu; Shiyin Ma; Zhendong Chen
Journal:  Oncol Lett       Date:  2015-01-23       Impact factor: 2.967

2.  Cervical lymphadenopathy: what radiologists need to know.

Authors:  Vincent Chong
Journal:  Cancer Imaging       Date:  2004-06-25       Impact factor: 3.909

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.